Histrelin Implantation and Growth Outcomes in Children with Congenital Adrenal Hyperplasia: an Institutional Experience

Background: Children with congenital adrenal hyperplasia (CAH) because of 21 hydroxylase deficiency (21OHD) are at risk for early or precocious puberty and a short adult height compared to population means and midparental height. The effect of histrelin in suppressing puberty and improving growth in these children has not been reported. Methods: Retrospective cohort analysis of all patients (age